Volume 19, Number 10—October 2013
Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: September 18, 2013; Expiration date: September 18, 2014
Upon completion of this activity, participants will be able to:
• Distinguish the most common underlying diagnosis of patients with invasive fusariosis in the current study
• Analyze the clinical presentation of patients with invasive fusariosis
• Assess the laboratory diagnosis and management of invasive fusariosis
• Evaluate trends in the incidence of fusariosis.
Shannon O’Connor, ELS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Shannon O’Connor has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Marcio Nucci, MD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Astellas, Pfizer, Merck, and Gilead; served as a speaker or a member of a speakers bureau for Pfizer, Merck, and Gilead; received grants for clinical research from Pfizer and Merck. Andrea G. Varon; Marcia Garnica; Tiyomi Akiti; Gloria Barreiros; Beatriz Trope, MD, PhD; and Simone A. Nouér, MD, have disclosed no relevant financial relationships.